Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion

Journal of Experimental Medicine

Volumn 210, Issue 1, 2013, Pages 99-114

  Peppa, Dimitra ^a   Gil, Upkar S ^a,b   Reynolds, Gary ^c   Easom, Nicholas J W ^a   Pallett, Laura J ^a   Schurich, Anna ^a   Micco, Lorenzo ^a   Nebbia, Gaia ^a   Singh, Harsimran D ^a   Adams, David H ^c   Kennedy, Patrick T F ^b   Maini, Mala K ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DEATH RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; AGED; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL CONTACT; CELL POPULATION; CELL SPECIFICITY; CELL SURVIVAL; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS LOAD;

EID: 84874543706     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20121172     Document Type: Article

References (48)

1. Alter, G., D. Heckerman, A. Schneidewind, L. Fadda, C.M. Kadie, J.M. Carlson, C. Oniangue-Ndza, M. Martin, B. Li, S.I. Khakoo, et al. 2011. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature. 476:96-100. http://dx.doi.org/10.1038/nature10237
2. Andrews, D.M., M.J. Estcourt, C.E. Andoniou, M.E. Wikstrom, A. Khong, V. Voigt, P. Fleming, H. Tabarias, G.R. Hill, R.G. van der Most, et al. 2010. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 207:1333-1343. http://dx.doi .org/10.1084/jem.20091193
3. Boni, C., P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, et al. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81:4215-4225. http://dx.doi .org/10.1128/JVI.02844-06
4. Bouillet, P., and L.A. O'Reilly. 2009. CD95, BIM and T cell homeostasis. Nat. Rev. Immunol. 9:514-519. http://dx.doi.org/10.1038/nri2570
5. Cerboni, C., A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati, and A. Santoni. 2007. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood. 110:606-615. http:// dx.doi.org/10.1182/blood-2006-10-052720
6. Cummins, N., and A. Badley. 2009. The TRAIL to viral pathogenesis: the good, the bad and the ugly. Curr. Mol. Med. 9:495-505. http://dx.doi .org/10.2174/156652409788167078
7. Dunn, C., M. Brunetto, G. Reynolds, T. Christophides, P.T. Kennedy, P. Lampertico, A. Das, A.R. Lopes, P. Borrow, K. Williams, et al. 2007. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204:667-680. http://dx.doi.org/10.1084/jem.20061287
8. Glässner, A., M. Eisenhardt, B. Krämer, C. Körner, M. Coenen, T. Sauerbruch, U. Spengler, and J. Nattermann. 2012. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner. Lab. Invest. 92:967-977. http://dx.doi.org/10.1038/labinvest .2012.54
9. Han, J., L.A. Goldstein, B.R. Gastman, and H. Rabinowich. 2006. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J. Biol. Chem. 281:10153-10163. http://dx.doi .org/10.1074/jbc.M510349200
10. Hildeman, D.A., T. Mitchell, T.K. Teague, P. Henson, B.J. Day, J. Kappler, and P.C. Marrack. 1999. Reactive oxygen species regulate activationinduced T cell apoptosis. Immunity. 10:735-744. http://dx.doi.org/ 10.1016/S1074-7613(00)80072-2
11. Holz, L.E., V. Benseler, D.G. Bowen, P. Bouillet, A. Strasser, L. O'Reilly, W.M. d'Avigdor, A.G. Bishop, G.W. McCaughan, and P. Bertolino. 2008. Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology. 135:989-997. http://dx.doi.org/10.1053/j.gastro.2008.05.078
12. Ichikawa, K., W. Liu, L. Zhao, Z. Wang, D. Liu, T. Ohtsuka, H. Zhang, J.D. Mountz, W.J. Koopman, R.P. Kimberly, and T. Zhou. 2001. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat. Med. 7:954-960. http://dx.doi.org/ 10.1038/91000
13. Janssen, H.L., H. Higuchi, A. Abdulkarim, and G.J. Gores. 2003. Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression. J. Hepatol. 39:414-420. http://dx.doi.org/10.1016/ S0168-8278(03)00265-4
14. Janssen, E.M., N.M. Droin, E.E. Lemmens, M.J. Pinkoski, S.J. Bensinger, B.D. Ehst, T.S. Griffith, D.R. Green, and S.P. Schoenberger. 2005. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature. 434:88-93. http://dx.doi.org/ 10.1038/nature03337
15. Jeremias, I., I. Herr, T. Boehler, and K.M. Debatin. 1998. TRAIL/Apo- 2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 28: 143-152.
16. Katsikis, P.D., M.E. Garcia-Ojeda, J.F. Torres-Roca, I.M. Tijoe, C.A. Smith, L.A. Herzenberg, and L.A. Herzenberg. 1997. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J. Exp. Med. 186:1365-1372. http:// dx.doi.org/10.1084/jem.186.8.1365
17. Khakoo, S.I., C.L. Thio, M.P. Martin, C.R. Brooks, X. Gao, J. Astemborski, J. Cheng, J.J. Goedert, D. Vlahov, M. Hilgartner, et al. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 305:872-874.
18. Kimberley, F.C., and G.R. Screaton. 2004. Following a TRAIL: update on a ligand and its five receptors. Cell Res. 14:359-372. http://dx.doi.org/ 10.1038/sj.cr.7290236
19. Kulkarni, S., M.P. Martin, and M. Carrington. 2008. The Yin and Yang of HLA and KIR in human disease. Semin. Immunol. 20:343-352. http:// dx.doi.org/10.1016/j.smim.2008.06.003
20. Kwon, D., K. Choi, C. Choi, and E.N. Benveniste. 2008. Hydrogen peroxide enhances TRAIL-induced cell death through up-regulation of DR5 in human astrocytic cells. Biochem. Biophys. Res. Commun. 372:870-874. http://dx.doi.org/10.1016/j.bbrc.2008.05.148
21. Lang, P.A., K.S. Lang, H.C. Xu, M. Grusdat, I.A. Parish, M. Recher, A.R. Elford, S. Dhanji, N. Shaabani, C.W. Tran, et al. 2012. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc. Natl. Acad. Sci. USA. 109:1210-1215. http://dx.doi.org/10.1073/pnas.1118834109
22. Lee, S.H., K.S. Kim, N. Fodil-Cornu, S.M. Vidal, and C.A. Biron. 2009. Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J. Exp. Med. 206:2235-2251. http://dx.doi.org/10.1084/jem.20082387
23. Lodoen, M.B., and L.L. Lanier. 2006. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18:391-398. http://dx.doi.org/ 10.1016/j.coi.2006.05.002
24. Lopes, A.R., P. Kellam, A. Das, C. Dunn, A. Kwan, J. Turner, D. Peppa, R.J. Gilson, A. Gehring, A. Bertoletti, and M.K. Maini. 2008. Bimmediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J. Clin. Invest. 118:1835-1845. http://dx.doi.org/ 10.1172/JCI33402
25. Lu, L., K. Ikizawa, D. Hu, M.B. Werneck, K.W. Wucherpfennig, and H. Cantor. 2007. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity. 26:593-604. http:// dx.doi.org/10.1016/j.immuni.2007.03.017
26. Maini, M.K., C. Boni, C.K. Lee, J.R. Larrubia, S. Reignat, G.S. Ogg, A.S. King, J. Herberg, R. Gilson, A. Alisa, et al. 2000. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191:1269-1280. http://dx.doi.org/ 10.1084/jem.191.8.1269
27. Martín-Fontecha, A., L.L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5:1260-1265. http://dx.doi.org/10.1038/ni1138
28. Mirandola, P., C. Ponti, G. Gobbi, I. Sponzilli, M. Vaccarezza, L. Cocco, G. Zauli, P. Secchiero, F.A. Manzoli, and M. Vitale. 2004. Activated human NK and CD8+ T cells express both TNF-related apoptosisinducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity. Blood. 104:2418-2424. http://dx.doi.org/ 10.1182/blood-2004-04-1294
29. Miura, Y., N. Misawa, N. Maeda, Y. Inagaki, Y. Tanaka, M. Ito, N. Kayagaki, N. Yamamoto, H. Yagita, H. Mizusawa, and Y. Koyanagi. 2001. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J. Exp. Med. 193:651-660. http://dx.doi.org/ 10.1084/jem.193.5.651
30. Morandi, B., G. Bougras, W.A. Muller, G. Ferlazzo, and C. Münz. 2006. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur. J. Immunol. 36:2394-2400. http://dx.doi.org/ 10.1002/eji.200636290
31. Orange, J.S., M.S. Fassett, L.A. Koopman, J.E. Boyson, and J.L. Strominger. 2002. Viral evasion of natural killer cells. Nat. Immunol. 3:1006-1012. http://dx.doi.org/10.1038/ni1102-1006
32. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5:201-214. http://dx.doi.org/ 10.1038/nri1570
33. Peppa, D., L. Micco, A. Javaid, P.T. Kennedy, A. Schurich, C. Dunn, C. Pallant, G. Ellis, P. Khanna, G. Dusheiko, et al. 2010. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog. 6:e1001227. http://dx.doi.org/ 10.1371/journal.ppat.1001227
34. Protzer, U., M.K. Maini, and P.A. Knolle. 2012. Living in the liver: hepatic infections. Nat. Rev. Immunol. 12:201-213. http://dx.doi.org/10.1038/ nri3169
35. Rabinovich, B.A., J. Li, J. Shannon, R. Hurren, J. Chalupny, D. Cosman, and R.G. Miller. 2003. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170:3572-3576.
36. Schneider, P., M. Thome, K. Burns, J.L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, and J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity. 7:831-836. http://dx.doi.org/10.1016/S1074-7613(00)80401-X
37. Schneider, P., N. Holler, J.L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205-1213. http://dx.doi.org/ 10.1084/jem.187.8.1205
38. Seich Al Basatena, N.K., A. Macnamara, A.M. Vine, C.L. Thio, J. Astemborski, K. Usuku, M. Osame, G.D. Kirk, S.M. Donfield, J.J. Goedert, et al. 2011. KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog. 7:e1002270. http://dx.doi.org/10.1371/journal.ppat.1002270
39. Soderquest, K., T. Walzer, B. Zafirova, L.S. Klavinskis, B. Policá, E. Vivier, G.M. Lord, and A. Martín-Fontecha. 2011. Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses. J. Immunol. 186:3304-3308. http://dx.doi.org/10.4049/jimmunol.1004122
40. Sprick, M.R., M.A. Weigand, E. Rieser, C.T. Rauch, P. Juo, J. Blenis, P.H. Krammer, and H. Walczak. 2000. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity. 12:599-609. http://dx.doi.org/ 10.1016/S1074-7613(00)80211-3
41. Su, H.C., K.B. Nguyen, T.P. Salazar-Mather, M.C. Ruzek, M.Y. Dalod, and C.A. Biron. 2001. NK cell functions restrain T cell responses during viral infections. Eur. J. Immunol. 31:3048-3055.
42. Takeda, K., Y. Hayakawa, M.J. Smyth, N. Kayagaki, N. Yamaguchi, S. Kakuta, Y. Iwakura, H. Yagita, and K. Okumura. 2001. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7:94-100. http:// dx.doi.org/10.1038/83416
43. Vezys, V., D. Masopust, C.C. Kemball, D.L. Barber, L.A. O'Mara, C.P. Larsen, T.C. Pearson, R. Ahmed, and A.E. Lukacher. 2006. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 203:2263-2269. http:// dx.doi.org/10.1084/jem.20060995
44. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9:503-510. http://dx .doi.org/10.1038/ni1582
45. Waggoner, S.N., R.T. Taniguchi, P.A. Mathew, V. Kumar, and R.M. Welsh. 2010. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. J. Clin. Invest. 120:1925-1938. http://dx.doi.org/ 10.1172/JCI41264
46. Waggoner, S.N., M. Cornberg, L.K. Selin, and R.M. Welsh. 2012. Natural killer cells act as rheostats modulating antiviral T cells. Nature. 481:394-398.
47. Wuensch, S.A., J. Spahn, and I.N. Crispe. 2010. Direct, help-independent priming of CD8+ T cells by adeno-associated virus-transduced hepatocytes. Hepatology. 52:1068-1077. http://dx.doi.org/10.1002/hep.23745
48. Zingoni, A., T. Sornasse, B.G. Cocks, Y. Tanaka, A. Santoni, and L.L. Lanier. 2004. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J. Immunol. 173: 3716-3724.